Soluble triggering receptor expressed on myeloid cells-1 Is an early marker of infection in the surgical intensive care unit

Surgical Infections

Volumn 10, Issue 5, 2009, Pages 435-439

  Rivera Chavez, Fernando A ^a   Minei, Joseph P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; PERITONEAL FLUID; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; SURGICAL INFECTION; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; INFECTION; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MYELOID CELLS; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 72449168881     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2009.030     Document Type: Article

References (26)

1. Salvo I, De Cian W, Musicco M, et al. The Italian SEPSIS study: Preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 1995;21(Suppl 2):S244-S249.
2. Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-1554.
3. Dulhunty JM, Lipman J, Finfer S. Does severe non-infectious SIRS differ from severe sepsis? Results from a multi-centre Australian and New Zealand intensive care unit study. Intensive Care Med 2008;34:1654-1661.
4. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM=ESICM= ACCP=ATS=SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-1256.
5. Bhatia M. Acute pancreatitis as a model of SIRS. Front Biosci 2009;14:2042-2050.
6. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM=ESICM= ACCP=ATS=SIS International Sepsis Definitions Conference. Intensive Care Med 2003;29:530-538.
7. Peduzzi P, Shatney C, Sheagren J, et al. Predictors of bacteremia and gram-negative bacteremia in patients with sepsis. The Veterans Affairs Systemic Sepsis Cooperative Study Group. Arch Intern Med 1992;152:529-535.
8. Otero RM, Nguyen HB, Huang DT, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: Concepts, controversies, and contemporary findings. Chest 2006; 130:1579-1595.
9. Jiyong J, Tiancha H, Wei C, et al. Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: A meta-analysis. Intensive Care Med 2009;35:587-595.
10. Knapp S, Gibot S, De Vos A, et al. Cutting edge: Expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol 2004; 173:7131-7134.
11. Determann RM, Olivier van Till JW, van Ruler O, et al. sTREM-1 is a potential useful biomarker for exclusion of ongoing infection in patients with secondary peritonitis. Cytokine 2009;46:36-42.
12. Gibot S, Cravoisy A, Levy B, et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004;350:451-458.
13. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: The ACCP=SCCM Consensus Conference Committee. American College of Chest Physicians=Society of Critical Care Medicine. Chest 1992;101:1644-1655.
14. Carlet J. Rapid diagnostic methods in the detection of sepsis. Infect Dis Clin North Am 1999;13:483-494.
15. Chan MC, Chang KM, Chao WC, et al. Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. Respirology 2007;12:333-338.
16. Gibot S, Le Renard PE, Bollaert PE, et al. Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med 2005;31:594-597. (Pubitemid 40543894)
17. Gibot S, Kolopp-Sarda MN, Bene MC, et al. Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004;141:9-15.
18. Gibot S, Cravoisy A, Dupays R, et al. Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis 2007;39:604-608.
19. Gibot S, Cravoisy A. Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clin Med Res 2004;2:181-187.
20. Georges H, Leroy O, Guery B. Soluble TREM-1 and the diagnosis of pneumonia. N Engl J Med 2004;350:1904-1905.
21. Collins CE, La DT, Yang HT, et al. Elevated synovial expression of triggering receptor expressed on myeloid cells-1 (TREM-1) in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis 2008; e-pub Dec 3.
22. Allaouchiche B, Boselli E. Soluble TREM-1 and the diagnosis of pneumonia. N Engl J Med 2004350:1904-1905.
23. Bouchon A, Facchetti F, Weigand MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001;410:1103-1107.
24. Gibot S, Cravoisy A, Kolopp-Sarda MN, et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 2005;33:792-796.
25. Gibot S. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia and severe sepsis. Semin Respir Crit Care Med 2006;27:29-33. (Pubitemid 43334728)
26. Yasuda T, Takeyama Y, Ueda T, et al. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Crit Care Med 2008;36: 2048-2053.